Smith Beth Ann 4

What Happened
Beth Ann Smith, VP, Controller & Treasurer of MacroGenics (MGNX), had restricted stock units (RSUs) vest and convert into 4,200 common shares on Feb 7–8, 2026 (2,617 on Feb 7 and 1,583 on Feb 8). To satisfy tax withholding, 1,011 shares were surrendered on Feb 7 for $1.81/share ($1,830) and 612 shares on Feb 8 for $1.81/share ($1,108), totaling 1,623 shares withheld and proceeds of $2,938. Net shares added to her position = 4,200 − 1,623 = 2,577 shares. The Form 4 filed Feb 10, 2026 records these conversions and the tax-withholding disposition.

Key Details

• Transaction dates: conversions on 2026-02-07 (2,617 RSUs) and 2026-02-08 (1,583 RSUs); tax-withholding disposals on the same dates.
• Withholding sale price: $1.81 per share; amounts withheld: 1,011 shares ($1,830) and 612 shares ($1,108); total $2,938.
• Net new shares retained: 2,577 shares.
• Footnotes: RSUs convert one-for-one to common stock (F1). The 2,617 shares came from a 2/7/2025 grant of 7,850 RSUs vesting in three equal installments (F2). The 1,583 shares came from a 2/8/2024 grant of 4,750 RSUs vesting in three equal installments (F3).
• Derivative lines showing $0 reflect the RSU-to-share conversion (exercise/conversion of derivative).
• Filing: Form 4 filed 2026-02-10; appears to report the Feb 7–8 vesting and withholding.

Context
These transactions are routine RSU vesting and tax withholding (a common "sell to cover" or share-for-tax payment), not an open-market sale intended as a liquidity or sentiment signal. No purchases were reported. The filing shows conversion of previously granted RSUs into shares and surrendering a portion to meet tax obligations.